Bleeding Disorders Flashcards

1
Q

What are the two main categories of bleeding disorders?

A

Congenital and Acquired

Congenital disorders are present from birth, while acquired disorders develop later in life.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the normal haemostatic mechanisms involved in bleeding control?

A

Vessel Wall, Platelets, von Willebrand Factor, Coagulation Factors

These mechanisms work together to prevent excessive bleeding.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the primary phase of the haemostatic response?

A

Platelet Plug Formation

This phase involves the aggregation of platelets at the site of injury.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the secondary phase of the haemostatic response?

A

Fibrin Plug Formation

This phase involves the formation of a stable fibrin clot.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What does haemorrhagic diathesis refer to?

A

Any quantitative or qualitative abnormality inhibiting function of platelets, vWF, or coagulation factors

It indicates a predisposition to bleeding.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the key points to assess in a bleeding history?

A
  • Has the patient actually got a bleeding disorder?
  • How severe is the disorder?
  • Pattern of bleeding
  • Congenital or acquired
  • Mode of inheritance

A thorough bleeding history is critical for diagnosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are common patterns of bleeding associated with platelet disorders?

A
  • Mucosal
  • Epistaxis
  • Purpura
  • Menorrhagia
  • GI

These symptoms often indicate issues with platelet function.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are common patterns of bleeding associated with coagulation factor disorders?

A
  • Articular
  • Muscle Haematoma
  • CNS
  • Rectus Sheath Haematoma
  • Intracranial Haemorrhage

These symptoms suggest problems with coagulation factors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the mode of inheritance for Haemophilia A and B?

A

X-linked

Both types of haemophilia are inherited through the X chromosome.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the severity classifications for haemophilia based on residual coagulation factor activity?

A
  • <1% Severe
  • 1-5% Moderate
  • 5-30% Mild

The classification helps determine treatment strategies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the clinical features of haemophilia?

A
  • Haemarthrosis
  • Muscle haematoma
  • CNS bleeding
  • Retroperitoneal bleeding
  • Post surgical bleeding

These features are indicative of bleeding diathesis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the typical diagnostic procedure for haemophilia?

A
  • Clinical assessment
  • Family history
  • Pattern of bleeding
  • Isolated prolonged APTT
  • Normal PT
  • Reduced FVIII or FIX
  • Genetic analysis

These steps ensure accurate diagnosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the treatment options for severe haemophilia?

A
  • Prophylaxis with recombinant factor concentrates
  • Emicizumab
  • On demand factor for bleeding episodes
  • Extended half-life factor concentrate

Treatment strategies vary based on severity and patient needs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is Emicizumab?

A

A recombinant, humanised, bispecific monoclonal antibody that bridges activated factor IX and factor X

It mimics the function of missing activated factor VIII.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is von Willebrand Disease?

A

A common bleeding disorder with variable severity, characterized by quantitative and qualitative abnormalities of vWF

It is the most prevalent inherited bleeding disorder.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the types of von Willebrand Disease?

A
  • Type 1 - Quantitative deficiency
  • Type 2 (A, B, M, N) - Qualitative deficiency
  • Type 3 - Severe (complete) deficiency

Each type has different implications for treatment.

17
Q

What are common acquired bleeding disorders?

A
  • Thrombocytopenia
  • Liver failure
  • Renal failure
  • DIC
  • Drugs (e.g., Warfarin, Heparin)

These conditions can lead to significant bleeding risks.

18
Q

What are the clinical features of thrombocytopenia?

A
  • Petechia
  • Ecchymosis
  • Mucosal bleeding
  • Rare CNS bleeding

Thrombocytopenia often results in easy bruising and bleeding.

19
Q

What is the management approach for immune thrombocytopenic purpura (ITP)?

A
  • Acute - Steroids, IVIg
  • Long-term - Thrombopoietin analogues, Immunosuppression
  • Splenectomy - Rare these days

Management strategies depend on whether the condition is acute or chronic.

20
Q

What is the primary prevention for Haemorrhagic Disease of the Newborn?

A

Administration of vitamin K at birth

This condition is preventable and can lead to severe bleeding if not treated.

21
Q

True or False: Bleeding disorders can result from disruption at any stage of haemostasis.

A

True

Understanding the stages of haemostasis is crucial for diagnosing and managing bleeding disorders.

22
Q

Extended half life factor concentrate

A

. In adults and adolescents (≥12 years)
EHL-FVIII products have an average increase in half-life of about 1.5 times compared to the standard FVIII concentrates
EHL-FIX products have a 3–5 fold increase in half-life compared to standard FIX concentrates

23
Q

Emicizumab

A

Recombinant, humanised, bispecific monoclonal antibody
Bridges activated factor IX and factor X, mimicking the function of missing activated factor VIII
Prophylaxis
Subcutaneous
Can be used in patients with inhibitors

24
Q

Gene therapy

A

Adeno-associated virus (AAV) vector that carries a copy of the factor VIII/ IX gene
Hemgenix (Factor IX)

25
Q

Mild haemophilia
Treatment

A

On demand
Bleeding episodes and peri-operatively
Recombinant factor concentrate
DDAVP (Haemophilia A)
Tranexamic Acid

26
Q

Severe haemophilia treatment

A

Prophylaxis
Recombinant factor concentrates
EHL or SHL
Emicizumab for haemophilia A
On demand factor for bleeding episodes